INS and type 2 diabetes mellitus: Modified DFs fed to T2D mice improved insulin receptor activity and insulin signaling transduction to inhibit hepatic gluconeogenesis, while promoting the synthesis of SCFAs, driving gastrointestinal hormone and insulin regulation of blood glucose, and reducing blood glucose levels in diabetic mice.